PatenSee

Name

PatenSee

Legal name

PatenSee

Website

https://patensee.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Vascular Access Monitoring Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)

akta.pro primary industry

Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ)

akta.pro secondary industry

Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)

Keywords

• Vascular access monitoring
• Hemodialysis surveillance
• Contactless medical imaging
• AI-enabled medical devices
• Vascular stenosis detection

Headquarters

HQ city

Or Yehuda

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales: Pre-revenue clinical-stage company. The company plans commercial launch in 2026 following FDA approval. Revenue expected from sale of monitoring devices and potentially associated services to dialysis clinics.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

PatenSee develops the PatenSee System, a contactless optical imaging device that standardizes and digitizes the 'look, listen, feel' physical examination of vascular access sites in hemodialysis patients. The system combines multi-modal imaging (subdermal imaging of collateral veins, 3D imaging, and optical listening for pulsatility and vibration) with AI/ML algorithms to perform a 1-2 minute non-contact assessment for early prediction of stenosis and other fistula complications.

Product overview

PatenSee offers a single unified product: the PatenSee System. This is a contactless vascular access monitoring system that combines multi-modal imaging technologies with AI/machine learning. The system comprises three integrated components — Look (subdermal imaging of collateral veins, 3D imaging), Listen & Feel (optical non-contact pulsatility and vibration detection), and Machine Learning (pattern recognition algorithms that simulate vascular access status for early stenosis identification). The system is designed for weekly use in hemodialysis clinics, completing imaging in 1-2 minutes per patient session to enable early detection of fistula complications.

Differentiator

Problem solved

Functional benefit

Products and services

• PatenSee System A contactless optical vascular access monitoring system that uses multi-modal imaging (subdermal imaging, 3D imaging, optical listening) combined with AI and machine learning to perform a 1-2 minute non-contact assessment of hemodialysis patients' vascular access sites. Designed for weekly use in hemodialysis clinics to enable early detection of stenosis and fistula complications.

Quantifiable outcome

• Assessment time reduced to 1-2 minutes compared to 7+ minutes for traditional monitoring methods
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Henry Ford HealthcoreStrategic or Co-development Partner · 6 June 2025Henry Ford Health initiated a clinical trial agreement with PatenSee for a prospective, international, multicenter, non-interventional, single-arm, blinded feasibility study with 40 patients. Lead investigators are Dr. Lalathaksha Kumbar and Dr. Sandeep Soman.
• Fresenius Medical CarecoreStrategic or Co-development Partner · 15 February 2024PatenSee entered a clinical collaboration agreement with Fresenius Medical Care for a joint multi-center pilot trial of PatenSee's contactless monitoring system in Fresenius' dialysis clinics in Israel, with plans to expand to US sites.
• Sheba Medical CentercoreStrategic or Co-development PartnerSheba Medical Center provides clinical support and partnership through MEDX Xelerator, offering access to clinical expertise and research facilities.
• Clalit Health ServicesminorStrategic or Co-development PartnerIsraeli HMO partnership for first-in-human study of 60 patients over 1.5 years, with results presented at World Congress of Nephrology 2022.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• DaVita: Largest US dialysis services provider; a key target customer for PatenSee with significant clinical purchasing power over vascular access monitoring tools.
• Fresenius Medical Care: World's largest dialysis services and products provider; a PatenSee clinical partner but also a potential competitor with internal R&D in vascular access surveillance.
• Medtronic: Major medical device incumbent with peripheral vascular diagnostics and AI-enabled imaging assets that could be repurposed for vascular access monitoring.
• Becton Dickinson (BD): Large diversified medical device manufacturer with a meaningful vascular access / dialysis product line; a potential acquirer or competitor in vascular access surveillance.
• Baxter International: Global renal care incumbent offering dialysis systems, fluids, and PD solutions; a relevant incumbent in the renal care ecosystem where PatenSee's system would deploy.

Direct peers

• Outset Medical: Maker of the Tablo in-clinic/home hemodialysis system; a direct adjacency to PatenSee's hemodialysis clinic workflow, addressing the same clinical user base.
• Quanta Dialysis Technologies: Developer of a compact hemodialysis system aimed at clinic and home use; competes for innovation dollars and clinical mindshare within the dialysis device ecosystem.
• Vascular Access Centers (Vasc-Alert): A clinical surveillance and analytics platform focused on vascular access monitoring for hemodialysis patients; competes directly with PatenSee on early detection of access complications.

Others

• Natus Medical: Provider of clinical monitoring and diagnostic neurology/patient monitoring equipment; adjacent in non-contact patient monitoring technology applicable to dialysis clinics.

Emerging players

• AWAK Technologies: Singapore-based developer of a wearable peritoneal dialysis device; an emerging dialysis technology innovator pursuing the same end-stage renal disease market with adjacent modality.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/patensee

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PatenSee